Abiopharma

Clinical trial NCT07615192 updates: 1. completion date: 2026-07-20 → 2026-08-20 2. primary completion date: 2026-07-20 → 2026-08-20

Clinical trial NCT04641442: completion date: 2032-04-07 → 2032-11-23.

Clinical trial NCT07316114 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2029-11-22 → 2026-06-02 3. primary completion date: 2027-11-24 → 2026-06-02 4. enrollment: 400 → 1 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT03108495: intervention model: SINGLE_GROUP → PARALLEL.

Clinical trial NCT07545265 updates: 1. start date: 2026-06-01 → 2026-09-01 2. completion date: 2029-05-01 → 2029-08-01 3. primary completion date: 2028-12-01 → 2029-03-01

Clinical trial NCT07712874: start date: 2026-08-04 → 2026-08-05.

Clinical trial NCT07645651: start date: 2026-07-01 → 2026-10-01.

Clinical trial NCT06087627 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-12-28 → 2027-12-31 3. primary completion date: 2026-06-06 → 2026-06-29 4. enrollment: 150 → 110 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT03888105: primary completion date: 2026-07-06 → 2026-06-17.

Clinical trial NCT05901649 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-05 → 2026-06-16 3. primary completion date: 2026-06-05 → 2026-06-16 4. enrollment: 504 → 505 participants

Clinical trial NCT05265273: primary completion date: 2026-06-26 → 2027-06-30.

Clinical trial NCT05169333: collaborators removed: National Consortium of Intelligent Medical Imaging.

Clinical trial NCT05316155 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment type: ESTIMATED → ACTUAL

Southern Cross Acquisition I Corp. - Ordinary Shares (NCO) was added to the exchange traded list on NASDAQ

Southern Cross Acquisition I Corp. - Rights (NCOOR) was added to the exchange traded list on NASDAQ